Racial and ethnic differences in preferences for health states and the implications for cost-utility analysis

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 9, Issue 4, 2009, Pages 365-373

  Saalfrank, Megan F ^a   Wang, Junling ^a   Brown, Lawrence M ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF PHARMACY   (United States)

Author keywords

Cost utility analysis; Disparities; Ethnicity; Health state; Preference; Race; Race ethnicity specific measure; Utility score

Indexed keywords

ARTHROPLASTY; ARTICLE; COMORBIDITY; COST UTILITY ANALYSIS; DECISION MAKING; DEMOGRAPHY; DRUG COST; EDUCATION; ETHNICITY; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; INCOME; MEDLINE; QUALITY OF LIFE; RACE DIFFERENCE; SOCIOECONOMICS; VISUAL ANALOG SCALE; WELLBEING; ATTITUDE TO HEALTH; COST BENEFIT ANALYSIS; ECONOMICS; ETHNIC GROUP; ETHNOLOGY; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; PSYCHOLOGICAL ASPECT; RACE;

ATTITUDE TO HEALTH; CONTINENTAL POPULATION GROUPS; COST-BENEFIT ANALYSIS; DECISION MAKING; ETHNIC GROUPS; HEALTH POLICY; HEALTH STATUS; HUMANS;

EID: 70350462981     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.09.27     Document Type: Article

References (17)

1. Pharmacoeconomics and Outcomes: Applications for Patient Care (2nd Edition). Grauer D, Lee J, Odom T et al. (Eds). American College of Clinical Pharmacy, KS, USA (2003). •Reader-friendly introductions to pharmacoeconomics, including cost-utility analysis and outcomes research.
2. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes (3rd Edition). Oxford University Press, Oxford, UK (2005). •Intermediate-level textbook for economic evaluation. Includes technical details of each economic evaluation technique, including cost-utility analysis.
3. Rosen AB, Tsai JS, Downs SM. Variations in risk attitude across race, gender, and education. Med. Decis. Making 23(6), 511-517 (2003).
4. Jones CP. Levels of racism: a theoretical framework and a gardener's tale. Am. J. Public Health 90(8), 1212-1215 (2000). ••Provides a widely cited framework for understanding three levels of the causes for racial and ethnic disparities.
5. Russell LB, Gold MR, Siegel JE, Daniel N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. JAMA 276(14), 1172-1177 (1996).
6. Nguyen GC, Tuskey A, Bayless TM, LaVeist TA, Brant SR. Community-based health preferences for proctocolectomy: a race comparison. Dig. Dis. Sci. 53(3), 741-746 (2008). (Pubitemid 351317069)
7. Shaw JW, Johnson JA, Chen S, Levin JR, Coons SJ. Racial/ethnic differences in preferences for the EQ-5D health states: results from the US valuation study. J. Clin. Epidemiol. 60(5), 479-490 (2007). (Pubitemid 46529146)
8. Souchek J, Byrne MM, Kelly PA et al. Valuation of arthritis health states across ethnic groups and between patients and community members. Med. Care 43(9), 921-928 (2005). (Pubitemid 41323141)
9. Wittenberg E, Halpern E, Divi N, Prosser LA, Araki SS, Weeks JC. The effect of age, race and gender on preference scores for hypothetical health states. Qual. Life Res. 15(4), 645-653 (2006). (Pubitemid 43843972)
10. Cykert S, Jones JD, Kissling G, Hansen CJ. Racial differences in patients' perceptions of debilitated health states. J. Gen. Intern. Med. 14(4), 217-222 (1999). (Pubitemid 29196423)
11. Cykert S, Phifer N. Surgical decisions for early stage, non-small cell lung cancer: which racially sensitive perceptions of cancer are likely to explain racial variation in surgery? Med. Decis. Making 23(2), 167-176 (2003). (Pubitemid 36373399)
12. Gaskin DJ, Frick KD. Race and ethnic disparities in valuing health. Med. Decis. Making 28(1), 12-20 (2008).
13. Lubetkin EI, Jia H, Franks P, Gold MR. Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the US general population. Qual. Life Res. 14(10), 2187-2196 (2005). (Pubitemid 41674421)
14. Fu AZ, Kattan MW. Racial and ethnic differences in preference-based health status measure. Curr. Med. Res. Opin. 22(12), 2439-2448 (2006).
15. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult US population as assessed by the EQ-5D and Health Utilities Index. Med. Care 43(11), 1078-1086 (2005). (Pubitemid 41587593)
16. Sassi F, Le Grand J, Archard L. Equity versus efficiency: a dilemma for the NHS. If the NHS is serious about equity it must offer guidance when principles conflict. BMJ 323(7316), 762-763 (2001).
17. McClellan MB. Testimony of Mark B. McClellan, MD, PhD, Administrator. Centers for Medicare and Medicaid Services Before the House Committee on Ways & Means Subcommittee on Health Hearing on Implementation of the Medicare Prescription Drug Benefit. www.hhs.gov/asl/testify/t060503a.html (2006).